- Home
- JYNT vs CRVO Comparison
JYNT vs CRVO Comparison
Compare JYNT & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- CRVO
- Stock Information
- Founded
- JYNT 2010
- CRVO 2001
- Country
- JYNT United States
- CRVO United States
- Employees
- JYNT N/A
- CRVO N/A
- Industry
- JYNT Multi-Sector Companies
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- JYNT Miscellaneous
- CRVO Health Care
- Exchange
- JYNT Nasdaq
- CRVO Nasdaq
- Market Cap
- JYNT 179.2M
- CRVO 160.4M
- IPO Year
- JYNT 2014
- CRVO N/A
- Fundamental
- Price
- JYNT $11.75
- CRVO $9.60
- Analyst Decision
- JYNT Strong Buy
- CRVO Strong Buy
- Analyst Count
- JYNT 2
- CRVO 6
- Target Price
- JYNT $17.50
- CRVO $53.67
- AVG Volume (30 Days)
- JYNT 53.5K
- CRVO 84.0K
- Earning Date
- JYNT 11-07-2024
- CRVO 11-12-2024
- Dividend Yield
- JYNT N/A
- CRVO N/A
- EPS Growth
- JYNT N/A
- CRVO N/A
- EPS
- JYNT N/A
- CRVO N/A
- Revenue
- JYNT $120,795,620.00
- CRVO $10,066,550.00
- Revenue This Year
- JYNT $0.70
- CRVO $54.67
- Revenue Next Year
- JYNT N/A
- CRVO N/A
- P/E Ratio
- JYNT N/A
- CRVO N/A
- Revenue Growth
- JYNT 5.26
- CRVO 116.29
- 52 Week Low
- JYNT $8.60
- CRVO $5.85
- 52 Week High
- JYNT $17.82
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- JYNT 55.34
- CRVO 27.74
- Support Level
- JYNT $10.65
- CRVO $9.31
- Resistance Level
- JYNT $12.70
- CRVO $11.44
- Average True Range (ATR)
- JYNT 0.49
- CRVO 0.89
- MACD
- JYNT -0.00
- CRVO -0.21
- Stochastic Oscillator
- JYNT 53.66
- CRVO 7.37
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.